FIELD: medicine.
SUBSTANCE: invention describes application of 9-oxoacridine-10-acetic acid, it pharmaceutically acceptable salts and its ethers as additional means for treatment of conditions implying androgen action decrease is considered to be favourable, and method of condition treatment implying that androgen action decrease is considered to be favourable, and needy patient in introduced with effective amount of 9-oxoacridine-10-acetic acid it pharmaceutically acceptable salts and its ethers combined with hormonotherapy directed on androgen action decrease. Besides, method implies androgen-dependent tissue sensibility intensifying to antiandrogen hormonotherapy directed on androgen action decrease.
EFFECT: increased efficiency of antiandrogen hormonotherapy.
30 cl, 5 tbl, 9 ex
